You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (iii) Distribution of all outpatient clients by age group for each primary drug

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Mean age	Age known (base)	Age not known
Opiates	6.8	41.0	28.0	12.8	6.2	3.1	1.4	0.6	22.0	76659	23577
Cocaine	6.7	42.4	25.9	12.6	6.5	3.5	1.4	0.8	22.1	41453	10770
Stimulants	14.0	61.8	16.2	5.0	1.8	0.9	0.2	0.1	18.8	14545	3897
Hypnotics and sedatives	7.1	29.9	24.4	14.5	9.3	5.4	3.6	5.9	25.2	6647	2146
Hallucinogens	11.2	50.5	21.0	7.5	4.1	2.3	1.7	1.6	20.9	4682	761
Volatile substances	47.5	42.7	5.9	1.1	1.3	0.2	0.7	0.7	16.7	461	72
Cannabis	34.7	52.9	8.1	2.2	0.9	0.6	0.2	0.3	17.2	43649	15783
Other substances	12.0	42.6	16.5	8.0	4.0	0.9	2.8	13.3	26.6	1361	1368
Total	14.0	45.5	21.6	9.6	4.8	2.5	1.2	0.9	20.7	189457	58374

Notes:

Countries reporting data: BG, CZ, DK, IE, EL, ES, FR, IT, CY, LU, MT, NL, SK, FI, SE

Last data available from Spain refer to 2004.

The number of treatment clients in each country is listed in [Table TDI-7].

See also ''TDI-107-All outpatient age at first use and primary drug.xls'' on distribution by country and ''General notes for interpreting data'' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI outpatient treatment centres.